HYPONATREMIA IN COVID-19 PATIENTS

Hospital Nacional Profesor Alejandro Posadas250 enrolled

Overview

SYSTEMIC INFLAMMATION HAS BEEN ASSOCIATED WITH SEVERE COVID-19. HYPONATREMIA CAN RESULT FROM INFLAMMATION DUE TO NON-OSMOTIC STIMULI FOR VASOPRESSIN PRODUCTION. IN THIS PROSPECTIVE COHORT STUDY WE ANALIZED DATA FROM PATIENTS WITH COVID-19 AND THE ASOCIATION WITH HYPONATREMIA AND CLINICAL OUTCOMES.

Study Type

OBSERVATIONAL

Enrollment

250

Conditions

Hyponatremia Covid19 Corona Virus Infection

Eligibility

Sex: ALLMin age: 1 MonthMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * PATIENTS WITH SARS-CoV-2 INFECTION CONFIRMED BY PCR OF NASOPHARYNGEAL SWABS. Exclusion Criteria: \-

Locations (1)

Hospital Posadas

Buenos Aires, Argentina

Outcomes

Primary Outcomes

MORTALITY

HYPONATREMIA AND MORTALITY

Time frame: 30 DAYS

Secondary Outcomes

ICU HOSPITALIZATION

HYPONATREMIA AND ICU HOSPITALIZATION

Time frame: 30 DAYS

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.